TULSA-Pro is a revolutionary, minimally invasive treatment option for men with prostate conditions, including localized prostate cancer and benign prostatic hyperplasia (BPH). Short for Transurethral Ultrasound Ablation, TULSA-Pro combines real-time MRI imaging with targeted ultrasound energy to precisely ablate prostate tissue while preserving surrounding structures.
TULSA-Pro is a robotic system-guided therapy that uses directional ultrasound waves to deliver thermal ablation directly to the prostate. What sets it apart is the integration of real-time MRI, allowing physicians to monitor and control the treatment with extreme accuracy. This means cancerous or enlarged tissue can be precisely targeted without damaging nearby nerves, the urethra, or the rectum.
Your eligibility will depend on factors such as prostate size, cancer stage, and overall health. An MRI and consultation with a urologist or interventional radiologist are essential steps in determining candidacy.
The TULSA-Pro treatment is performed under MRI guidance. A device is inserted through the urethra, and directional ultrasound energy is emitted in a controlled, rotating manner. The MRI scans the prostate in real time, helping doctors adjust energy delivery and monitor temperatures to ensure optimal results and safety.
Most procedures take about 2–3 hours. Because it’s a non-surgical approach, recovery is generally quicker, with many patients returning to normal activity within a few days.
TULSA-Pro is redefining how prostate conditions are treated. With its combination of precision, safety, and reduced side effects, it offers a compelling alternative for men seeking effective treatment without the trade-offs of traditional therapies. If you’re exploring options for prostate cancer or BPH, ask your doctor whether TULSA-Pro might be right for you.